TGFBR2 and colorectal carcinoma: This analysis allowed us to elucidate the mechanisms inducing the characteristics of CRC with TGFBR2 mutation and identify genes that may act as biomarkers or therapeutic targets in CRCs harboring TGFBR2 mutations.